Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters

Hypothalamic tanycytes are considered to function as sensors of peripheral metabolism [1]. To facilitate this role, they express a wide range of receptors, including fibroblast growth factor receptor 1 (FGFR1). Using a monoclonal antibody (IMC-H7) that selectively antagonizes the FGFR1c isoform [2],...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current biology 2015-11, Vol.25 (22), p.2997-3003
Hauptverfasser: Samms, Ricardo J., Lewis, Jo E., Lory, Alex, Fowler, Maxine J., Cooper, Scott, Warner, Amy, Emmerson, Paul, Adams, Andrew C., Luckett, Jeni C., Perkins, Alan C., Wilson, Dana, Barrett, Perry, Tsintzas, Kostas, Ebling, Francis J.P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3003
container_issue 22
container_start_page 2997
container_title Current biology
container_volume 25
creator Samms, Ricardo J.
Lewis, Jo E.
Lory, Alex
Fowler, Maxine J.
Cooper, Scott
Warner, Amy
Emmerson, Paul
Adams, Andrew C.
Luckett, Jeni C.
Perkins, Alan C.
Wilson, Dana
Barrett, Perry
Tsintzas, Kostas
Ebling, Francis J.P.
description Hypothalamic tanycytes are considered to function as sensors of peripheral metabolism [1]. To facilitate this role, they express a wide range of receptors, including fibroblast growth factor receptor 1 (FGFR1). Using a monoclonal antibody (IMC-H7) that selectively antagonizes the FGFR1c isoform [2], we investigated possible actions of FGFR1c in a natural animal model of adiposity, the Siberian hamster. Infusion of IMC-H7 into the third ventricle suppressed appetite and increased energy expenditure. Likewise, peripheral treatment with IMC-H7 decreased appetite and body weight and increased energy expenditure and fat oxidation. A greater reduction in body weight and caloric intake was observed in response to IMC-H7 during the long-day fat state as compared to the short-day lean state. This enhanced response to IMC-H7 was also observed in calorically restricted hamsters maintained in long days, suggesting that it is the central photoperiodic state rather than the peripheral adiposity that determines the response to FGFR1c antagonism. Hypothalamic thyroid hormone availability is controlled by deiodinase enzymes (DIO2 and DIO3) expressed in tanycytes and is the key regulator of seasonal cycles of energy balance [3, 4]. Therefore, we determined the effect of IMC-H7 on hypothalamic expression of these deiodinase enzymes. The reductions in food intake and body weight were always associated with decreased expression of DIO2 in the hypothalamic ependymal cell layer containing tanycytes. These data provide further support for the notion the tanycytes are an important component of the mechanism by which the hypothalamus integrates central and peripheral signals to regulate energy intake and expenditure. [Display omitted] •FGFR1c is expressed in the hamster ependymal cell layer containing tanycytes•Central or peripheral treatment with a mAb raised against FGFR1c reduces body weight•Weight loss reflects both a suppression of appetite and increased energy expenditure•FGFR1c blockade causes a decrease in deiodinase 2 gene expression in tanycytes Seasonal cycles of food intake and energy expenditure arise from changes in deiodinase gene expression and thyroid hormone production in hypothalamic tanycytes. Using a monoclonal antibody antagonist of FGFR1c, Samms et al. demonstrate that signaling via FGF receptors occurs through a similar pathway in tanycytes to regulate energy balance.
doi_str_mv 10.1016/j.cub.2015.10.010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1735329814</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960982215012385</els_id><sourcerecordid>1735329814</sourcerecordid><originalsourceid>FETCH-LOGICAL-c466t-87624db0b3fa86a94344d507a595361ae8d2e45888fd6f6e6ee8fe02a3f71c8e3</originalsourceid><addsrcrecordid>eNp9kE9LHDEYh0Np0dX6AXopOfYya5JJMhk8yeLqwpZCteeQSd5glp2JTTKC394sqx49vX943h-8D0I_KFlSQuXlbmnnYckIFXVeEkq-oAVVXd8QzsVXtCC9JE2vGDtFZznvCKFM9fIEnTIpeM9Et0D-eiphiO6l-Q0umAIOb6bHMIQS4oSjx-UR8Pp2_ZdavMnRxzRWwM0WMjZ4ZYoZ4j5YvAUz4ftSA3CoTRgghbq5M2MukPJ39M2bfYaLt3qO_q1vHlZ3zfbP7WZ1vW0sl7I0qpOMu4EMrTdKmp63nDtBOiN60UpqQDkGXCilvJNeggRQHggzre-oVdCeo1_H3KcU_8-Qix5DtrDfmwninDXtWtGyXlFeUXpEbYo5J_D6KYXRpBdNiT7o1Ttd9eqD3sOq6q03P9_i52EE93Hx7rMCV0cA6pPPAZLONsBkq9sEtmgXwyfxrwaFifU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1735329814</pqid></control><display><type>article</type><title>Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Samms, Ricardo J. ; Lewis, Jo E. ; Lory, Alex ; Fowler, Maxine J. ; Cooper, Scott ; Warner, Amy ; Emmerson, Paul ; Adams, Andrew C. ; Luckett, Jeni C. ; Perkins, Alan C. ; Wilson, Dana ; Barrett, Perry ; Tsintzas, Kostas ; Ebling, Francis J.P.</creator><creatorcontrib>Samms, Ricardo J. ; Lewis, Jo E. ; Lory, Alex ; Fowler, Maxine J. ; Cooper, Scott ; Warner, Amy ; Emmerson, Paul ; Adams, Andrew C. ; Luckett, Jeni C. ; Perkins, Alan C. ; Wilson, Dana ; Barrett, Perry ; Tsintzas, Kostas ; Ebling, Francis J.P.</creatorcontrib><description>Hypothalamic tanycytes are considered to function as sensors of peripheral metabolism [1]. To facilitate this role, they express a wide range of receptors, including fibroblast growth factor receptor 1 (FGFR1). Using a monoclonal antibody (IMC-H7) that selectively antagonizes the FGFR1c isoform [2], we investigated possible actions of FGFR1c in a natural animal model of adiposity, the Siberian hamster. Infusion of IMC-H7 into the third ventricle suppressed appetite and increased energy expenditure. Likewise, peripheral treatment with IMC-H7 decreased appetite and body weight and increased energy expenditure and fat oxidation. A greater reduction in body weight and caloric intake was observed in response to IMC-H7 during the long-day fat state as compared to the short-day lean state. This enhanced response to IMC-H7 was also observed in calorically restricted hamsters maintained in long days, suggesting that it is the central photoperiodic state rather than the peripheral adiposity that determines the response to FGFR1c antagonism. Hypothalamic thyroid hormone availability is controlled by deiodinase enzymes (DIO2 and DIO3) expressed in tanycytes and is the key regulator of seasonal cycles of energy balance [3, 4]. Therefore, we determined the effect of IMC-H7 on hypothalamic expression of these deiodinase enzymes. The reductions in food intake and body weight were always associated with decreased expression of DIO2 in the hypothalamic ependymal cell layer containing tanycytes. These data provide further support for the notion the tanycytes are an important component of the mechanism by which the hypothalamus integrates central and peripheral signals to regulate energy intake and expenditure. [Display omitted] •FGFR1c is expressed in the hamster ependymal cell layer containing tanycytes•Central or peripheral treatment with a mAb raised against FGFR1c reduces body weight•Weight loss reflects both a suppression of appetite and increased energy expenditure•FGFR1c blockade causes a decrease in deiodinase 2 gene expression in tanycytes Seasonal cycles of food intake and energy expenditure arise from changes in deiodinase gene expression and thyroid hormone production in hypothalamic tanycytes. Using a monoclonal antibody antagonist of FGFR1c, Samms et al. demonstrate that signaling via FGF receptors occurs through a similar pathway in tanycytes to regulate energy balance.</description><identifier>ISSN: 0960-9822</identifier><identifier>EISSN: 1879-0445</identifier><identifier>DOI: 10.1016/j.cub.2015.10.010</identifier><identifier>PMID: 26549257</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adiposity - physiology ; Animals ; Antibodies, Monoclonal - immunology ; Antibodies, Monoclonal - pharmacology ; Circadian Rhythm - physiology ; Cricetinae ; Eating - drug effects ; Hypothalamus - metabolism ; Male ; Models, Animal ; Phodopus ; Photoperiod ; Protein Isoforms - metabolism ; Receptor, Fibroblast Growth Factor, Type 1 - antagonists &amp; inhibitors ; Receptor, Fibroblast Growth Factor, Type 1 - immunology ; Receptor, Fibroblast Growth Factor, Type 1 - metabolism ; Thinness - metabolism ; Thyroid Hormones - metabolism ; Weight Loss - drug effects</subject><ispartof>Current biology, 2015-11, Vol.25 (22), p.2997-3003</ispartof><rights>2015 Elsevier Ltd</rights><rights>Copyright © 2015 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c466t-87624db0b3fa86a94344d507a595361ae8d2e45888fd6f6e6ee8fe02a3f71c8e3</citedby><cites>FETCH-LOGICAL-c466t-87624db0b3fa86a94344d507a595361ae8d2e45888fd6f6e6ee8fe02a3f71c8e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960982215012385$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26549257$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Samms, Ricardo J.</creatorcontrib><creatorcontrib>Lewis, Jo E.</creatorcontrib><creatorcontrib>Lory, Alex</creatorcontrib><creatorcontrib>Fowler, Maxine J.</creatorcontrib><creatorcontrib>Cooper, Scott</creatorcontrib><creatorcontrib>Warner, Amy</creatorcontrib><creatorcontrib>Emmerson, Paul</creatorcontrib><creatorcontrib>Adams, Andrew C.</creatorcontrib><creatorcontrib>Luckett, Jeni C.</creatorcontrib><creatorcontrib>Perkins, Alan C.</creatorcontrib><creatorcontrib>Wilson, Dana</creatorcontrib><creatorcontrib>Barrett, Perry</creatorcontrib><creatorcontrib>Tsintzas, Kostas</creatorcontrib><creatorcontrib>Ebling, Francis J.P.</creatorcontrib><title>Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters</title><title>Current biology</title><addtitle>Curr Biol</addtitle><description>Hypothalamic tanycytes are considered to function as sensors of peripheral metabolism [1]. To facilitate this role, they express a wide range of receptors, including fibroblast growth factor receptor 1 (FGFR1). Using a monoclonal antibody (IMC-H7) that selectively antagonizes the FGFR1c isoform [2], we investigated possible actions of FGFR1c in a natural animal model of adiposity, the Siberian hamster. Infusion of IMC-H7 into the third ventricle suppressed appetite and increased energy expenditure. Likewise, peripheral treatment with IMC-H7 decreased appetite and body weight and increased energy expenditure and fat oxidation. A greater reduction in body weight and caloric intake was observed in response to IMC-H7 during the long-day fat state as compared to the short-day lean state. This enhanced response to IMC-H7 was also observed in calorically restricted hamsters maintained in long days, suggesting that it is the central photoperiodic state rather than the peripheral adiposity that determines the response to FGFR1c antagonism. Hypothalamic thyroid hormone availability is controlled by deiodinase enzymes (DIO2 and DIO3) expressed in tanycytes and is the key regulator of seasonal cycles of energy balance [3, 4]. Therefore, we determined the effect of IMC-H7 on hypothalamic expression of these deiodinase enzymes. The reductions in food intake and body weight were always associated with decreased expression of DIO2 in the hypothalamic ependymal cell layer containing tanycytes. These data provide further support for the notion the tanycytes are an important component of the mechanism by which the hypothalamus integrates central and peripheral signals to regulate energy intake and expenditure. [Display omitted] •FGFR1c is expressed in the hamster ependymal cell layer containing tanycytes•Central or peripheral treatment with a mAb raised against FGFR1c reduces body weight•Weight loss reflects both a suppression of appetite and increased energy expenditure•FGFR1c blockade causes a decrease in deiodinase 2 gene expression in tanycytes Seasonal cycles of food intake and energy expenditure arise from changes in deiodinase gene expression and thyroid hormone production in hypothalamic tanycytes. Using a monoclonal antibody antagonist of FGFR1c, Samms et al. demonstrate that signaling via FGF receptors occurs through a similar pathway in tanycytes to regulate energy balance.</description><subject>Adiposity - physiology</subject><subject>Animals</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Circadian Rhythm - physiology</subject><subject>Cricetinae</subject><subject>Eating - drug effects</subject><subject>Hypothalamus - metabolism</subject><subject>Male</subject><subject>Models, Animal</subject><subject>Phodopus</subject><subject>Photoperiod</subject><subject>Protein Isoforms - metabolism</subject><subject>Receptor, Fibroblast Growth Factor, Type 1 - antagonists &amp; inhibitors</subject><subject>Receptor, Fibroblast Growth Factor, Type 1 - immunology</subject><subject>Receptor, Fibroblast Growth Factor, Type 1 - metabolism</subject><subject>Thinness - metabolism</subject><subject>Thyroid Hormones - metabolism</subject><subject>Weight Loss - drug effects</subject><issn>0960-9822</issn><issn>1879-0445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9LHDEYh0Np0dX6AXopOfYya5JJMhk8yeLqwpZCteeQSd5glp2JTTKC394sqx49vX943h-8D0I_KFlSQuXlbmnnYckIFXVeEkq-oAVVXd8QzsVXtCC9JE2vGDtFZznvCKFM9fIEnTIpeM9Et0D-eiphiO6l-Q0umAIOb6bHMIQS4oSjx-UR8Pp2_ZdavMnRxzRWwM0WMjZ4ZYoZ4j5YvAUz4ftSA3CoTRgghbq5M2MukPJ39M2bfYaLt3qO_q1vHlZ3zfbP7WZ1vW0sl7I0qpOMu4EMrTdKmp63nDtBOiN60UpqQDkGXCilvJNeggRQHggzre-oVdCeo1_H3KcU_8-Qix5DtrDfmwninDXtWtGyXlFeUXpEbYo5J_D6KYXRpBdNiT7o1Ttd9eqD3sOq6q03P9_i52EE93Hx7rMCV0cA6pPPAZLONsBkq9sEtmgXwyfxrwaFifU</recordid><startdate>20151116</startdate><enddate>20151116</enddate><creator>Samms, Ricardo J.</creator><creator>Lewis, Jo E.</creator><creator>Lory, Alex</creator><creator>Fowler, Maxine J.</creator><creator>Cooper, Scott</creator><creator>Warner, Amy</creator><creator>Emmerson, Paul</creator><creator>Adams, Andrew C.</creator><creator>Luckett, Jeni C.</creator><creator>Perkins, Alan C.</creator><creator>Wilson, Dana</creator><creator>Barrett, Perry</creator><creator>Tsintzas, Kostas</creator><creator>Ebling, Francis J.P.</creator><general>Elsevier Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20151116</creationdate><title>Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters</title><author>Samms, Ricardo J. ; Lewis, Jo E. ; Lory, Alex ; Fowler, Maxine J. ; Cooper, Scott ; Warner, Amy ; Emmerson, Paul ; Adams, Andrew C. ; Luckett, Jeni C. ; Perkins, Alan C. ; Wilson, Dana ; Barrett, Perry ; Tsintzas, Kostas ; Ebling, Francis J.P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c466t-87624db0b3fa86a94344d507a595361ae8d2e45888fd6f6e6ee8fe02a3f71c8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adiposity - physiology</topic><topic>Animals</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Circadian Rhythm - physiology</topic><topic>Cricetinae</topic><topic>Eating - drug effects</topic><topic>Hypothalamus - metabolism</topic><topic>Male</topic><topic>Models, Animal</topic><topic>Phodopus</topic><topic>Photoperiod</topic><topic>Protein Isoforms - metabolism</topic><topic>Receptor, Fibroblast Growth Factor, Type 1 - antagonists &amp; inhibitors</topic><topic>Receptor, Fibroblast Growth Factor, Type 1 - immunology</topic><topic>Receptor, Fibroblast Growth Factor, Type 1 - metabolism</topic><topic>Thinness - metabolism</topic><topic>Thyroid Hormones - metabolism</topic><topic>Weight Loss - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Samms, Ricardo J.</creatorcontrib><creatorcontrib>Lewis, Jo E.</creatorcontrib><creatorcontrib>Lory, Alex</creatorcontrib><creatorcontrib>Fowler, Maxine J.</creatorcontrib><creatorcontrib>Cooper, Scott</creatorcontrib><creatorcontrib>Warner, Amy</creatorcontrib><creatorcontrib>Emmerson, Paul</creatorcontrib><creatorcontrib>Adams, Andrew C.</creatorcontrib><creatorcontrib>Luckett, Jeni C.</creatorcontrib><creatorcontrib>Perkins, Alan C.</creatorcontrib><creatorcontrib>Wilson, Dana</creatorcontrib><creatorcontrib>Barrett, Perry</creatorcontrib><creatorcontrib>Tsintzas, Kostas</creatorcontrib><creatorcontrib>Ebling, Francis J.P.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Samms, Ricardo J.</au><au>Lewis, Jo E.</au><au>Lory, Alex</au><au>Fowler, Maxine J.</au><au>Cooper, Scott</au><au>Warner, Amy</au><au>Emmerson, Paul</au><au>Adams, Andrew C.</au><au>Luckett, Jeni C.</au><au>Perkins, Alan C.</au><au>Wilson, Dana</au><au>Barrett, Perry</au><au>Tsintzas, Kostas</au><au>Ebling, Francis J.P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters</atitle><jtitle>Current biology</jtitle><addtitle>Curr Biol</addtitle><date>2015-11-16</date><risdate>2015</risdate><volume>25</volume><issue>22</issue><spage>2997</spage><epage>3003</epage><pages>2997-3003</pages><issn>0960-9822</issn><eissn>1879-0445</eissn><abstract>Hypothalamic tanycytes are considered to function as sensors of peripheral metabolism [1]. To facilitate this role, they express a wide range of receptors, including fibroblast growth factor receptor 1 (FGFR1). Using a monoclonal antibody (IMC-H7) that selectively antagonizes the FGFR1c isoform [2], we investigated possible actions of FGFR1c in a natural animal model of adiposity, the Siberian hamster. Infusion of IMC-H7 into the third ventricle suppressed appetite and increased energy expenditure. Likewise, peripheral treatment with IMC-H7 decreased appetite and body weight and increased energy expenditure and fat oxidation. A greater reduction in body weight and caloric intake was observed in response to IMC-H7 during the long-day fat state as compared to the short-day lean state. This enhanced response to IMC-H7 was also observed in calorically restricted hamsters maintained in long days, suggesting that it is the central photoperiodic state rather than the peripheral adiposity that determines the response to FGFR1c antagonism. Hypothalamic thyroid hormone availability is controlled by deiodinase enzymes (DIO2 and DIO3) expressed in tanycytes and is the key regulator of seasonal cycles of energy balance [3, 4]. Therefore, we determined the effect of IMC-H7 on hypothalamic expression of these deiodinase enzymes. The reductions in food intake and body weight were always associated with decreased expression of DIO2 in the hypothalamic ependymal cell layer containing tanycytes. These data provide further support for the notion the tanycytes are an important component of the mechanism by which the hypothalamus integrates central and peripheral signals to regulate energy intake and expenditure. [Display omitted] •FGFR1c is expressed in the hamster ependymal cell layer containing tanycytes•Central or peripheral treatment with a mAb raised against FGFR1c reduces body weight•Weight loss reflects both a suppression of appetite and increased energy expenditure•FGFR1c blockade causes a decrease in deiodinase 2 gene expression in tanycytes Seasonal cycles of food intake and energy expenditure arise from changes in deiodinase gene expression and thyroid hormone production in hypothalamic tanycytes. Using a monoclonal antibody antagonist of FGFR1c, Samms et al. demonstrate that signaling via FGF receptors occurs through a similar pathway in tanycytes to regulate energy balance.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>26549257</pmid><doi>10.1016/j.cub.2015.10.010</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-9822
ispartof Current biology, 2015-11, Vol.25 (22), p.2997-3003
issn 0960-9822
1879-0445
language eng
recordid cdi_proquest_miscellaneous_1735329814
source MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Adiposity - physiology
Animals
Antibodies, Monoclonal - immunology
Antibodies, Monoclonal - pharmacology
Circadian Rhythm - physiology
Cricetinae
Eating - drug effects
Hypothalamus - metabolism
Male
Models, Animal
Phodopus
Photoperiod
Protein Isoforms - metabolism
Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors
Receptor, Fibroblast Growth Factor, Type 1 - immunology
Receptor, Fibroblast Growth Factor, Type 1 - metabolism
Thinness - metabolism
Thyroid Hormones - metabolism
Weight Loss - drug effects
title Antibody-Mediated Inhibition of the FGFR1c Isoform Induces a Catabolic Lean State in Siberian Hamsters
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T14%3A13%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibody-Mediated%20Inhibition%20of%20the%20FGFR1c%20Isoform%20Induces%20a%20Catabolic%20Lean%20State%20in%20Siberian%20Hamsters&rft.jtitle=Current%20biology&rft.au=Samms,%20Ricardo%C2%A0J.&rft.date=2015-11-16&rft.volume=25&rft.issue=22&rft.spage=2997&rft.epage=3003&rft.pages=2997-3003&rft.issn=0960-9822&rft.eissn=1879-0445&rft_id=info:doi/10.1016/j.cub.2015.10.010&rft_dat=%3Cproquest_cross%3E1735329814%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1735329814&rft_id=info:pmid/26549257&rft_els_id=S0960982215012385&rfr_iscdi=true